<DOC>
	<DOCNO>NCT01590615</DOCNO>
	<brief_summary>This registry remain open approximately 5 year ( 4 year enrollment + 1 year follow ) . Subjects follow Orthotopic Liver Transplant ( OLT ) , resolution liver decompensation , death , conclusion registry .</brief_summary>
	<brief_title>Registry Study Patients With Chronic HBV Receiving Nucleotide Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>Inclusions : Estimated glomerular filtration rate ( CockcroftGault method ) use actual body weight â‰¥ 50 mL/min time entry registry Negative serology HIV , hepatitis C virus ( HCV ) , and/or hepatitis D virus ( HDV ) No history solid organ bone marrow transplant Currently receive anticipate receive antiHBV nucleoside/nucleotide therapy within 6 month inclusion registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hepatitis</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>HBV</keyword>
	<keyword>OLT</keyword>
	<keyword>MELD</keyword>
	<keyword>Renal Safety</keyword>
	<keyword>Liver Transplant</keyword>
</DOC>